Focus Medica India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 0.21 M
as on 18-12-2024
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.38 M
as on 18-12-2024
- Satisfied Charges ₹ 2.70 M
as on 18-12-2024
- Revenue -73.85%
(FY 2020)
- Profit -357.66%
(FY 2020)
- Ebitda -171.91%
(FY 2020)
- Net Worth -25.90%
(FY 2020)
- Total Assets -34.11%
(FY 2020)
About Focus Medica India
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.21 M.
The company currently has active open charges totaling ₹1.38 M. The company has closed loans amounting to ₹2.70 M, as per Ministry of Corporate Affairs (MCA) records.
Sophie Rajasekharan, Puzhakalidom Rajasekharan, and Padmaja Rao serve as directors at the Company.
- CIN/LLPIN
U22212KA2009PTC049305
- Company No.
049305
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Focus Medica India?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Padmaja Rao | Director | 31-Mar-2010 | Current |
Sophie Rajasekharan | Director | 06-Mar-2009 | Current |
Puzhakalidom Rajasekharan | Director | 06-Mar-2009 | Current |
Financial Performance of Focus Medica India.
Focus Medica India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 73.85% decrease. The company also saw a substantial fall in profitability, with a 357.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 25.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Focus Medica India?
In 2019, Focus Medica India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Panther Publishers Private LimitedActive 30 years 8 months
Sophie Rajasekharan, Puzhakalidom Rajasekharan and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 24 Sep 2021 | ₹1.38 M | Open |
Others Creation Date: 25 Nov 2011 | ₹2.70 M | Satisfied |
How Many Employees Work at Focus Medica India?
Unlock and access historical data on people associated with Focus Medica India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Focus Medica India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Focus Medica India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.